● Recruiting

REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs

Condition: Anthracycline-induced Cardiac Toxicity · Lymphoma · Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

PhaseNA

Planned participants608

Who can joinAll sexes, 18 Years to 99 Years

Healthy volunteersNo

About this study

Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic PreConditioning (RIPC) in Lymphoma patients receiving anthracyclines.

This description comes directly from the study's public registry record.

Talk to the study team

Borja Ibañez, MD PhD FESC · 914501200 · bibanez@cnic.es

Noemi Escalera · 914501200 · nescalera@cnic.es

Always discuss trial participation with your own doctor first.

Locations (24)

Aarhus University	Aarhus, Denmark	Recruiting
Hospital Jaques Monod, El Havre	Montivilliers, France	Not Yet Recruiting
Henri Becquerel	Rouen, France	Recruiting
University Hospital Duesseldorf UDUS	Düsseldorf, Germany	Recruiting
Amsterdam UMC	Amsterdam, Netherlands	Not Yet Recruiting
Hospital da Luz Learning Health (GLSMED)	Lisbon, Portugal	Recruiting
IPO Lisboa	Lisbon, Portugal	Recruiting
Hospital Universitario Príncipe de Asturias	Alcalá de Henares, Spain	Not Yet Recruiting
Centro Medico Teknon	Barcelona, Spain	Recruiting
Instituto Catalán de Oncología	Barcelona, Spain	Recruiting
Hospital Universitario Virgen de las Nieves	Granada, Spain	Recruiting
Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Madrid, Spain	Recruiting

+ 12 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05223413